<DOC>
	<DOC>NCT02197806</DOC>
	<brief_summary>A study to evaluate the safety and efficacy of AGN-199201 alone, AGN-190584 alone and concurrent use of AGN-199201 and AGN-190584 in patients with presbyopia (inability to focus for near vision).</brief_summary>
	<brief_title>Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia</brief_title>
	<detailed_description />
	<mesh_term>Presbyopia</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Presbyopia in each eye that impacts daily activities. Use of any topical ophthalmic medications, including artificial tears Contact lens use in either eye within 14 days or planned use during the study History of eye surgery Diagnosis of any type of glaucoma or ocular hypertension</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>